Li Z, Lu S. Who Should Receive the Chemotherapy-Free Combination of Nivolumab Plus Ipilimumab as the First-Line Treatment of Advanced Non-Small-Cell Lung Cancer? J Clin Oncol 2023 Jan 9:JCO2202278. doi: 10.1200/JCO.22.02278.
PMID: 36623229